Skip to content
Review Open access

Cellular Mechanisms Enabling Mitochondria Transfer and Transplantation

Oct 2026 · Advancement of science · 0 citations · 178 references
Medicine

TL;DR

This work critically synthesizes the cellular mechanisms enabling mitoTT, emphasizing the checkpoints that determine whether transferred mitochondria are integrated, remodeled, immunologically sensed, or eliminated.

Abstract

ABSTRACT Mitochondrial transfer and transplantation (mitoTT) has emerged as an experimental and potentially transformative therapeutic strategy, drawing attention for its ability to modulate cellular bioenergetics, stress responses, and tissue repair. Endogenous mitochondrial transfer can occur through tunneling nanotubes, extracellular vesicles, cell fusion, gap junction‐associated communication, and phagocytosis‐like internalization. These routes differ substantially in distance, directionality, cargo integrity, regulatory control, and physiological relevance. Preclinical studies indicate that exogenous mitochondria may transiently improve bioenergetic function, attenuate oxidative stress, and support recovery in models of cardiac, skeletal muscle, and nervous system injury, whereas clinical evidence remains limited and heterogeneous. Broad clinical implementation remains constrained by unresolved biological and translational barriers. These include inefficient or poorly controlled uptake of extracellular mitochondria, uncertain long‐term persistence, incomplete functional integration, donor‐recipient incompatibility, mitochondrial‐nuclear mismatch, heteroplasmy‐related risks, immunogenicity, and the lack of standardized potency and delivery assays. Here, we critically synthesize the cellular mechanisms enabling mitoTT, emphasizing the checkpoints that determine whether transferred mitochondria are integrated, remodeled, immunologically sensed, or eliminated. We further discuss cristae biology and the mitochondrial contact site and cristae organizing system, mitochondrial nucleoid maintenance, mitochondrial DNA replication, organelle contact sites, and emerging bioengineering strategies required to move mitoTT from experimental rescue toward reproducible therapeutic application.

Read PDF

Similar papers

Review Open access Oct 2026

Augmenting intercellular mitochondrial transfer for tissue repair and rejuvenation

Cells exhibit innate reparative communication, enabling the exchange of bioactive molecules and, in some cases, entire organelles. Harnessing this endogenous process of intercellular organelle transfer represents an emerging therapeutic paradigm for restoring cellular function in diseases driven by organelle dysfunctio...

John Soukar, K. Jones, Natalie M. Garza et al. · 0 citations
Review Open access Oct 2026

Mitochondrial Transplantation as a Therapeutic Strategy: From Energy Replacement to Metabolic and Immune Reprogramming.

Mitochondrial dysfunction drives diseases, including ischemia-reperfusion injury, neurodegenerative disorders, cardiovascular disease, metabolic syndrome, and inflammation. Conventional mitochondria-targeted strategies offer only partial rescue and are insufficient for severe, irreversible damage. Mitochondrial transpl...

Chu-Lin Zhu, M. Xu, Ya-Nan Ji et al. · 0 citations
Review Open access Oct 2026

After delivery: How recipient cells shape the fate and function of transplanted mitochondria

Abstract Background Mitochondrial transplantation is built on a simple idea: failing cells might be rescued by healthy mitochondria. The approach has entered early clinical testing, and encapsulation and cell‐type targeting have improved uptake in selected systems. Better delivery, however, does not explain the therapy...

Zhi-Yuan Zhang, Bo-Quan Qin, Shi-Zhou Wu et al. · 0 citations
Open access Nov 2026

Mitochondrial transplantation for kidney disease: evidence, delivery constraints, and translational priorities

Mitochondrial dysfunction underlies multiple forms of renal injury, prompting strategies to restore organellar function rather than target discrete signaling pathways. Mitochondrial transplantation (MTx) has produced short-term functional, histological, or cellular benefits in preclinical models of renal ischemia-rep...

Yu Cheng, Hong Liu, Kai-Feng Zheng et al. · 0 citations
Review Open access Oct 2026

Recent Advances in Mitochondria-Targeted Delivery Strategies for Ischemic Stroke Therapy

Abstract Ischemic stroke remains a leading cause of death and disability, and mitochondrial dysfunction links bioenergetic failure, oxidative stress, neuroinflammation, blood–brain barrier (BBB) injury, and cell death. Despite extensive preclinical neuroprotection research, translation has often failed because candidat...

Ye-Wu Ding, Xiu-Fei Teng, Ting-Yi Guo et al. · 0 citations
Review Oct 2026

Mitochondrial transfer in cancer-immune crosstalk.

This review delineates how mitochondrial transfer exerts dual effects on antitumor immunity: tumor cells hijack functional mitochondria from T cells, macrophages, and stromal cells to fuel their proliferation and therapy resistance, while simultaneously delivering mutant mitochondria to immune cells to drive exhaustion...

Yu-Han Chen, Zhan-Gui Tang, Jing-Yi Cheng · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.